Fig. 2From: N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarctionIncidence of in-hospital mortality (a) and major clinical adverse events (b) according to different C-ACS-RS group or Bio-C-CACS-RS groupBack to article page